Effects of forsythoside A administration on: A) fasting blood glucose; B) body weight; C) food intake; and D) water intake in diabetic mice. *** p<0.001 vs control. # p<0.05; ## p<0.01; ### p<0.001 vs DM. DM – diabetic mice; FA – forsythoside A; MET – metformin
Figure 3
Effects of forsythoside A administration on oxidative stress parameters in diabetic mice. ** p<0.01; *** p<0.001 vs control. # p<0.05, ## p<0.01, ### p<0.001 vs DM. DM – diabetic mice; FA – forsythoside A; MET – metformin
Figure 4
Changes in lipid accumulation in diabetic mice treated with forsythoside A. *** p<0.001 vs control. # p<0.05; ### p<0.001 vs DM. DM – diabetic mice; FA – forsythoside A; HDL – high-density lipoprotein; LDL – low-density lipoprotein; MET – metformin; TC – total cholesterol; TG – triglycerides
Figure 5
Histopathological changes in diabetic mice treated with forsythoside A vs control (200× magnification) visualised with A) HE staining showing focal necroses (circles) and mussy hepatic cords (arrows) and B) PAS staining showing hepatocyte glycogen accumulation (arrows). DM – diabetic mice; FA – forsythoside A; HE – haematoxylin and eosin; MET – metformin; PAS – periodic acid and Schiff
Figure 6
Forsythoside A-induced changes in A) serum insulin and B) p-IRS-1 expression in diabetic mice *** p<0.001 vs control. # p<0.05; ### p<0.001 vs DM. DM – diabetic mice; FA – forsythoside A; MET – metformin
Figure 7
Forsythoside A-mediated changes in MAPK and Nrf2 pathways in diabetic mice. *** p<0.001 vs control. # p<0.05; ### p<0.001 vs DM. DM – diabetic mice; FA – forsythoside A; MET – metformin